phone
phone
-
195
-
December 2019
$4700
Research Reports in Pulmonary Arterial Hypertension
-
Intravenous-to-Subcutaneous Drug Repositioning Market By Product (Device Analysis and Drug Product Analysis), By Therapeutic Sector (Cardiology, Edema, Pulmonary Arterial Hypertension, Hematology, Blood Factors, and Oncology), By Technology (Drug Formulation, Injection Site Modification, and Device Innovation), Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2018-2026
-
Pulmonary Arterial Hypertension Market by Drug Class (Endothelin Receptor Antagonists (ERAs), Prostacyclin and Prostacyclin Analogs, Phosphodiesterase-5 (PDE-5) Inhibitors, and Soluble Guanylate Cyclase (sGC) Stimulators); By Application (Hospitals, Clinics, and Others); By Geography (North America, Asia-Pacific, Europe, South America, and RoW), Industry Analysis, COVID-19 Impact Analysis, Size, Share, Growth, Trends, and Forecasts 2021-2028
-
180
-
April 2018
$4700 -
